How much is Teladoc Health stock worth?
With Teladoc Health stock trading at $72.90 per share, the total value of Teladoc Health stock (market capitalization) is $11.67B. Teladoc Health stock was originally listed at a price of $28.50 in Jul 1, 2015.
What is Teladoc Health (TDOC)?
Teladoc Health ( TDOC 2.07%) offers virtual healthcare services in the United States and internationally, with primary and specialty care telehealth solutions along with chronic care and mental healthcare.
What does TDOC stand for?
Teladoc Health, Inc. Common Stock (TDOC) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Teladoc Health, Inc. Common Stock (TDOC) Pre-Market Quotes | Nasdaq Skip to main content Logo-halfwhite Created with Sketch.
Should you buy Teladoc Health (TDOC) when momentum runs dry?
Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024. Cathie Wood has a knack for growth stocks, but she can also be forgiving when momentum runs dry. The founder, CEO, and chief investment officer of ARK Invest made it a point to buy into some of her biggest laggards on Thursday.
Is teladoc overvalued?
Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.
Is teladoc publicly traded?
After beginning the process that April, Teladoc went public on the New York Stock Exchange on July 1, 2015. The only telemedicine company on the NYSE, Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million.
Is teladoc good to buy?
Teladoc Health, Inc. (NYSE:TDOC) delivered a -39.02% return since the beginning of the year, while its 12-month returns are down by -67.23%. The stock closed at $55.99 per share on April 25, 2022. "Teladoc is the largest telehealth provider in the US and has recently begun to expand internationally.
What is the forecast for teladoc stock?
Stock Price Forecast The 23 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 42.00, with a high estimate of 65.00 and a low estimate of 30.00. The median estimate represents a +3.35% increase from the last price of 40.64.
Why is Teladoc stock dropping?
What happened. Shares of Teladoc Health (TDOC 4.88%) went down in flames on Thursday, plunging as much as 47.8%. At 10:28 a.m. ET, the stock was down 46.3%. The catalyst that sent the digital healthcare company plummeting was first-quarter financial results that were far worse than investors had anticipated.
Why is Teladoc not profitable?
Despite added sales due to COVID-19 in 2020, the acquisition of Livongo led to expenses that made it seem like the company might never be profitable. The first year that Teladoc actually generated cash rather than burning it was 2019. In that year, cash flow from operations (CFFO) was 5% of sales.
Is Teladoc undervalued?
The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.
Did Cathie sell Teladoc?
In addition to the flagship fund, Ark Invest also bought Teladoc in the Ark Next Generation Internet ETF (ARKW), Ark Genomic Revolution ETF (ARKG), and Ark Fintech Revolution ETF (ARKF). With Cathie Wood's firm seeing massive inflows in 2020, the firm bought millions of shares of Teladoc across these funds.
Will Teladoc go back up?
The global telehealth market, at a compound annual growth rate of more than 36%, is expected to reach $787.4 billion by 2028, according to Grand View Research. In an investor presentation earlier this year, Teladoc said 60% of consumers expressed interest in a virtual plan.
Who are teladoc competitors?
Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.
What is going on with teladoc?
Teladoc also predicts losses to widen in the first quarter to between 50 and 60 cents per share. The stock's price dip following the results reflects a steady downward trend for the company's shares, which suffered considerably in 2021, plummeting 54% compared with the S&P 500's 27% gain.
Should I buy TDOC Stockinvest?
Teladoc Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Should I buy or sell Teladoc Health stock right now?
26 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 18...
What is Teladoc Health's stock price forecast for 2022?
26 brokers have issued twelve-month price objectives for Teladoc Health's shares. Their forecasts range from $30.00 to $210.00. On average, they pr...
How has Teladoc Health's stock performed in 2022?
Teladoc Health's stock was trading at $91.82 at the beginning of 2022. Since then, TDOC shares have decreased by 65.4% and is now trading at $31.74...
Are investors shorting Teladoc Health?
Teladoc Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 38,200,000 shares, an in...
When is Teladoc Health's next earnings date?
Teladoc Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022. View our earnings forecast for Teladoc...
How were Teladoc Health's earnings last quarter?
Teladoc Health, Inc. (NYSE:TDOC) announced its earnings results on Wednesday, April, 27th. The health services provider reported ($41.58) EPS for t...
What guidance has Teladoc Health issued on next quarter's earnings?
Teladoc Health updated its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided earnings per share (EPS) guidance of $-1.600-$-1...
Who are Teladoc Health's key executives?
Teladoc Health's management team includes the following people: Mr. Jason Nathanial Gorevic , CEO & Director (Age 50, Pay $1.64M) Ms. Mala Murth...
What is Jason Gorevic's approval rating as Teladoc Health's CEO?
106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com . Jason Gorevic has an approval rating of 95% among Teladoc Health's em...
Is Teladoc stock a Buy, Sell or Hold?
Teladoc stock has received a consensus rating of buy. The average rating score is and is based on 59 buy ratings, 20 hold ratings, and 0 sell ratings.
What was the 52-week low for Teladoc stock?
The low in the last 52 weeks of Teladoc stock was 27.38. According to the current price, Teladoc is 115.92% away from the 52-week low.
What was the 52-week high for Teladoc stock?
The high in the last 52 weeks of Teladoc stock was 174.32. According to the current price, Teladoc is 18.21% away from the 52-week high.
What are analysts forecasts for Teladoc stock?
The 79 analysts offering price forecasts for Teladoc have a median target of 175.33, with a high estimate of 300.00 and a low estimate of 30.00. Th...
When will Teladoc Health release its earnings?
How much does Teladoc Health make?
Teladoc Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021. View our earnings forecast for Teladoc Health.
Mid Cap U.S. Pick List February 2022
Teladoc Health has a market capitalization of $22.35 billion and generates $1.09 billion in revenue each year. The health services provider earns $-485,140,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.
Mid Cap U.S. Pick List January 2022
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Weekly Stock List
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Mid Cap U.S. Pick List December 2021
Investors wrapped up a quiet final week in 2021 with a modest loss for the S&P 500. But that hardly dented a strong year for stocks, when the S&P 500 climbed almost 27%. The average stock in the Argus Universe of Coverage rose 24% during the quarter, and the median stock advanced 36%.
Mid Cap U.S. Pick List October 2021
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Mid Cap U.S. Pick List September 2021
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Market Digest: BTI, MMP, AMZN, ASH, BXP, CAT, EPD, F, FHI, HP, ITW, KLAC, LAZ, FB, HCA, HLT, NRZ, TDOC
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
New York Stock Exchange
The stock market was flat to down last week as positive earnings surprises proved to be baked-in. Tech stocks modestly underperformed blue chips. During Friday's session, the Dow Jones Industrial Average fell 149 points, or 0.42%. The S&P 500 was down 0.54%, and the Nasdaq Composite was down 0.71%.
Environmental, Social, and Governance Rating
Teladoc provides video-conferencing consultations for everyday customers with general medical professionals, dermatologists, and behavioral health specialists.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
